Technical Analysis for CIZ - Cizzle Biotechnology Holdings Plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 2.27 | 5.58% | 0.12 |
CIZ closed up 2.38 percent on Monday, March 18, 2024, on 3.58 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 5.58% | |
50 DMA Resistance | Bearish | 5.58% | |
Shooting Star Candlestick | Bearish | 5.58% | |
Lizard Bearish | Bearish Day Trade Setup | 5.58% | |
Crossed Above 200 DMA | Bullish | 5.58% | |
Pocket Pivot | Bullish Swing Setup | 5.58% | |
Volume Surge | Other | 5.58% | |
Bollinger Band Squeeze | Range Contraction | 5.58% | |
Wide Range Bar | Range Expansion | 5.58% | |
BB Squeeze + Upper Band Touch | Range Contraction | 5.58% |
Alert | Time |
---|---|
Down 1% | about 3 hours ago |
10 DMA Support | about 3 hours ago |
200 DMA Support | about 3 hours ago |
3x Volume Pace | about 3 hours ago |
2x Volume Pace | about 3 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Cizzle Biotechnology Holdings Plc engages in developing a blood test for the early detection of various forms of lung cancer. It develops CIZ1B protein gene and its potential as a diagnostic biomarker for detection and management of lung cancer. The company's Ciz1 promotes DNA replication and its organization and control. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc was incorporated in 2004 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Cancer Branches Of Biology Biology Biomarkers Lung Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Cancer Branches Of Biology Biology Biomarkers Lung Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.1 |
52 Week Low | 1.6325 |
Average Volume | 1,376,209 |
200-Day Moving Average | 2.12 |
50-Day Moving Average | 2.32 |
20-Day Moving Average | 2.18 |
10-Day Moving Average | 2.14 |
Average True Range | 0.19 |
RSI (14) | 46.24 |
ADX | 22.9 |
+DI | 20.07 |
-DI | 19.29 |
Chandelier Exit (Long, 3 ATRs) | 1.93 |
Chandelier Exit (Short, 3 ATRs) | 2.48 |
Upper Bollinger Bands | 2.33 |
Lower Bollinger Band | 2.04 |
Percent B (%b) | 0.39 |
BandWidth | 13.37 |
MACD Line | -0.05 |
MACD Signal Line | -0.05 |
MACD Histogram | -0.0018 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.73 | ||||
Resistance 3 (R3) | 2.79 | 2.64 | 2.64 | ||
Resistance 2 (R2) | 2.64 | 2.49 | 2.62 | 2.60 | |
Resistance 1 (R1) | 2.40 | 2.40 | 2.33 | 2.34 | 2.57 |
Pivot Point | 2.25 | 2.25 | 2.22 | 2.23 | 2.25 |
Support 1 (S1) | 2.01 | 2.11 | 1.94 | 1.96 | 1.73 |
Support 2 (S2) | 1.86 | 2.01 | 1.84 | 1.70 | |
Support 3 (S3) | 1.62 | 1.86 | 1.66 | ||
Support 4 (S4) | 1.57 |